Caen, France

Martine Brisset

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Adir Et Compagnie. Active years: 1991-1992.


% Patents Active = 100.0


Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Martine Brisset: Innovator in Thiophene Compounds

Introduction

Martine Brisset is a notable inventor based in Caen, France. She has made significant contributions to the field of chemistry, particularly in the development of thiophene compounds. With a total of 3 patents to her name, her work has implications in various therapeutic applications.

Latest Patents

Martine Brisset's latest patents include innovative thiophene compounds that serve as intermediates. One of her notable inventions is a new thiophene compound of the formula: ##STR1##, where X can represent hydrogen, halogen, C1-C5 alkyl or alkoxy, or dialkylamino. Additionally, she has developed new divalent metal salts of 2-[N,N-di(carboxymethyl)amino]-3-cyano-4-carboxymethylthiophene-5-carboxylic acid. These compounds are particularly useful in therapeutic settings, especially for treating bone diseases, cutaneous and vascular aging, hepatic diseases, and dental diseases.

Career Highlights

Martine Brisset is currently associated with Adir Et Compagnie, where she continues to innovate and contribute to her field. Her work has garnered attention for its potential applications in medicine and health.

Collaborations

Some of her notable coworkers include Michel Wierzbicki and Jacqueline Bonnet, who have collaborated with her on various projects.

Conclusion

Martine Brisset's contributions to the field of thiophene compounds highlight her innovative spirit and dedication to advancing therapeutic solutions. Her work continues to impact the scientific community positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…